Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14980798 | 0.76 | HTT (0.35) | LMNAHSD17B10 | |
| SCHEMBL24817709 | 0.76 | IDO1 (0.30) | — | |
| SCHEMBL16377542 | 0.76 | — | — | |
| SCHEMBL9296093 | 0.73 | ESR1 (0.38) | KDM4ELMNAHSD17B10 | |
| SCHEMBL5511692 | 0.73 | CA9 (0.50) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL21635507 | 0.72 | CYP3A4 (0.35) | KDM4E | |
| SCHEMBL13466234 | 0.72 | — | — | |
| SCHEMBL9819938 | 0.71 | ALOX15 (0.36) | KDM4E | |
| SCHEMBL9820018 | 0.71 | MAPT (0.42) | KDM4ELMNAHSD17B10GRIN2DGRIN3B | |
| SCHEMBL1005024 | 0.71 | TSHR (0.46) | HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2298312-B1 | Fluorinated resorufin compounds and their application in detecting hydrogen peroxide | MOLECULAR PROBES INC (US) | 2018-09-26 | — | — | EP | disclosed |
| US-20170037248-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Life Technologies Corporation | 2017-02-09 | — | — | US | disclosed |
| US-20170037248-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Life Technologies Corporation | 2017-02-09 | — | — | US | disclosed |
| US-20170037248-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Life Technologies Corporation | 2017-02-09 | — | — | US | disclosed |
| US-9212385-B2 | Fluorinated resorufin compounds and their application | Life Technologies Corporation (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212385-B2 | Fluorinated resorufin compounds and their application | Life Technologies Corporation (US) | 2015-12-15 | — | — | US | disclosed |
| EP-1685117-B1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE | LIFE TECHNOLOGIES CORP (US) | 2015-01-07 | — | — | EP | disclosed |
| US-20140220612-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Life Technologies Corporation (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140220612-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Life Technologies Corporation (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140220612-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | Life Technologies Corporation (US) | 2014-08-07 | — | — | US | disclosed |
| US-7875261-B2 | Fluorinated resorufin compounds and their application | Life Technologies Corporation (US) | 2011-01-25 | — | — | US | disclosed |
| US-7432372-B2 | for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | INVITROGEN CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432372-B2 | for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | INVITROGEN CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432372-B2 | for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | INVITROGEN CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-20080113341-A1 | Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | INVITROGEN CORPORATION (US) | 2008-05-15 | — | — | US | disclosed |
| US-20080113341-A1 | Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | INVITROGEN CORPORATION (US) | 2008-05-15 | — | — | US | disclosed |
| US-20080113341-A1 | Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | INVITROGEN CORPORATION (US) | 2008-05-15 | — | — | US | disclosed |
| EP-1685117-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE | Molecular Probes Inc. (US) | 2006-08-02 | — | — | EP | disclosed |
| WO-2005042504-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION IN DETECTING HYDROGEN PEROXIDE | MOLECULAR PROBES, INC. (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20050096315-A1 | for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | Life Technologies Corporation | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037248-A1 | FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION | CYP2F1, CYP4F2, CYP4F3 | CA3 4452/4885CA6 4063/4885CA5A 1914/4885 |
| US-20050096315-A1 | for detecting reactive oxygen species, e.g., hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays | GPX4, PRDX3, MPO | CA3 3692/4885CA6 2898/4885CA5A 644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.